| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |